These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23072618)

  • 1. Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'.
    Prall F; Maletzki C; Linnebacher M
    Histopathology; 2012 Nov; 61(5):823-32. PubMed ID: 23072618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TUFM is a potential new prognostic indicator for colorectal carcinoma.
    Shi H; Hayes M; Kirana C; Miller R; Keating J; Macartney-Coxson D; Stubbs R
    Pathology; 2012 Oct; 44(6):506-12. PubMed ID: 22772342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
    Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
    Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis.
    Sun L; Pan J; Peng L; Fang L; Zhao X; Sun L; Yang Z; Ran Y
    Ann Surg Oncol; 2012 Jul; 19(7):2411-9. PubMed ID: 22219064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
    Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
    Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
    Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A
    Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer.
    Ahmed MA; Al-Attar A; Kim J; Watson NF; Scholefield JH; Durrant LG; Ilyas M
    J Clin Pathol; 2009 Dec; 62(12):1117-22. PubMed ID: 19946098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.
    Wu XR; He XS; Chen YF; Yuan RX; Zeng Y; Lian L; Zou YF; Lan N; Wu XJ; Lan P
    J Surg Oncol; 2012 Aug; 106(2):130-7. PubMed ID: 22287455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection.
    Ressine A; Corin I; Järås K; Guanti G; Simone C; Marko-Varga G; Laurell T
    Electrophoresis; 2007 Dec; 28(23):4407-15. PubMed ID: 18041036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB; Wu AG; Chen YJ; Tang BH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.
    Magnusson C; Mezhybovska M; Lörinc E; Fernebro E; Nilbert M; Sjölander A
    Eur J Cancer; 2010 Mar; 46(4):826-35. PubMed ID: 20064706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular CXCR4 expression in colorectal carcinoma.
    Ingold B; Schulz S; Budczies J; Neumann U; Ebert MP; Weichert W; Röcken C
    Histopathology; 2009 Nov; 55(5):576-86. PubMed ID: 19912363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.